The prognoses of patients with pancreatic adenocarcinoma (PAAD) remain poor due to the
lack of biomarkers for early diagnosis and effective prognosis prediction. RNA sequencing …

Pancreatic adenocarcinoma (PAC) is the most common type of pancreatic cancer, which
commonly has an unfavorable prognosis. The present study aimed to develop a novel …

Background: Pancreatic cancer is highly lethal and aggressive with increasing trend of
mortality in both genders. An effective prediction model is needed to assess prognosis of …

Predicting the prognosis of pancreatic cancer is important because of the very low survival
rates of patients with this particular cancer. Although several studies have used microRNA …

Background and aim Pancreatic cancer (PC) is one of the most common tumors with a poor
prognosis. The current American Joint Committee on Cancer (AJCC) staging system, based …

We systematically developed a prognostic model for pancreatic cancer that was compatible
across different transcriptomic platforms and patient cohorts. After performing quality control …

Pancreatic cancer is one of the most malignant tumors of the digestive system, with
insidious, rapid onset and high mortality. The 5-year survival rate is only 10%. Therefore, in …

Pancreatic cancer (PC) is associated with high mortality rates and poor prognoses.
Pancreatic adenocarcinoma is the most common type of PC, and almost all cases of …

Background Currently, prognostication for pancreatic ductal adenocarcinoma (PDAC) is
based upon a coarse clinical staging system. Thus, more accurate prognostic tests are …

Background Gene mutations play critical roles in tumorigenesis and cancer development.
Our study aimed to screen survival-related mutations and explore a novel gene signature to …